Plasmapheresis in Chronic Active Antibody Mediated Rejection.

被引：0
|
作者：
Oguz, E. Gok [1 ]
Yildirim, T. [1 ]
Merhametsiz, O. [1 ]
Haspulat, A. [1 ]
Ercan, Z. [1 ]
Gursoy, G. Karaveli [1 ]
Bulut, C. [1 ]
Akoglu, H. [1 ]
Akdag, I. [1 ]
Canbakan, B. [1 ]
Ayli, D. [1 ]
机构：
[1] Ankara Diskapi Yildirim Beyazit Training & Res Ho, Dept Nephrol, Ankara, Turkey
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C3034
引用
收藏
页码：677 / 677
页数：1
相关论文
共 50 条
  • [41] Analysis of Cost Effectiveness of Treatment for Acute Antibody-Mediated Rejection.
    McDermott, C.
    Carsky, K.
    Ferrin, P.
    Gaines, A.
    Chernobylsky, D.
    Killackey, M.
    Paramesh, A.
    Zhang, R.
    Buell, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 734 - 734
  • [42] RNA Sequencing Guided Identification of Shared mRNAs in Human Kidney Allograft Recipients with Acute T Cell Mediated Rejection or Active Antibody Mediated Rejection.
    Dooley, B.
    Verma, A.
    Ding, R.
    Li, C.
    Snopkowski, C.
    Yang, H.
    Botticelli, B.
    Albakry, S.
    Edusei, E.
    Muthukumar, T.
    Lubetzky, M.
    Dadhania, D.
    Lee, J.
    Elemento, O.
    Suthanthiran, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 592 - 592
  • [43] INHIBITION OF ANGIOTENSIN SIGNALING REDUCES INCIDENCE OF ANTIBODY MEDIATED ALLOGRAFT REJECTION.
    Shah, Sanjay K.
    Verma, Divya Ratan
    Snow, Greg
    Kfoury, Abadallah G.
    Bader, Feras
    Brunisholz, Kim
    Drakos, Stavros G.
    Hammond, Elizabeth M. E.
    Revelo, Monica P.
    Gilbert, Edward
    Alharethi, Rami
    Budge, Deborah
    Everitt, Melanie D.
    Selzman, Craig
    Stehlik, Josef
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [44] Increased Number of Intragraft FoxP3+T Cells is Strongly Correlated with Decreased Graft Survival in Chronic Active Antibody Mediated Rejection.
    Sablik, K.
    Jordanova, K.
    Clahsen-van Groningen, M.
    Betjes, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 669 - 669
  • [45] The Importance of HLA-Cw Typing in Avoiding Antibody Mediated Rejection.
    Dunn, Ty
    Noreen, H.
    Maurer, D.
    Humar, A.
    Kandaswamy, R.
    Sutherland, D.
    Payne, W.
    Matas, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 334 - 335
  • [46] A SEVERE CASE OF ANTIBODY MEDIATED REJECTION. HOW SHOULD WE TREAT ?
    Karava, Vasiliki
    Hennaut, Elise
    Lolin, Ksenija
    Chiodini, Benedetta Diamante
    Ismaili, Khalid
    Adams, Brigitte
    [J]. PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1725 - 1726
  • [47] The Role of Bortezomib in Pediatric Renal Transplant Recipients With Antibody Mediated Rejection.
    Nayak, A.
    Tsai, E.
    Ettenger, R.
    [J]. TRANSPLANTATION, 2014, 98 : 499 - 499
  • [48] Urinary cytokine and microparticles in antibody-mediated renal allograft rejection.
    Kamthan, Shubhi
    Singh, Snigdha Pratap
    Prasad, Narayan
    Agarwal, Vikas
    Agrawal, Vinita
    [J]. TRANSPLANTATION, 2024, 108 (09) : 18 - 18
  • [49] ANTIBODY-MEDIATED REJECTION IN LUNG TRANSPLANT RECIPIENTS TREATED WITH PLASMAPHERESIS
    Djordjevic, M.
    Sandhaus, T.
    Steinke, T.
    Leuze, M.
    Kirov, H.
    Faerber, G.
    Breuer, M.
    Steinert, M.
    Rummler, S.
    Doenst, T.
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 11 - 12
  • [50] Effect of Plasmapheresis on the Efficacy of Rituximab in Antibody-Mediated Rejection Patients
    Lee, Jin Ho
    Lee, Heeryong
    Kim, Kipyo
    Lee, Seoung Woo
    Song, Joon Ho
    Hwang, Seun Deuk
    [J]. TRANSPLANTATION PROCEEDINGS, 2024, 56 (03) : 723 - 725
12345